F 14413
Alternative Names: F-14413Latest Information Update: 16 Nov 2009
At a glance
- Originator Pierre Fabre
- Class Nootropics
- Mechanism of Action Alpha 2 adrenergic receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Parkinson's disease
Most Recent Events
- 02 Dec 2003 Preclinical trials in Alzheimer's disease in France (unspecified route)
- 02 Dec 2003 Preclinical trials in Parkinson's disease in France (unspecified route)